SLGL

+ Watchlist + Portfolio

Sol-Gel Technologies Ltd.

Regulated industry Physical productsTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $73.00
52-Week Range: $28.81 – $97.97
Market Cap: $235.73M
P/E (TTM): —
EPS (TTM): -5.61
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 4.90
PEG Ratio: —
Return on Equity: -40.85%
Return on Assets: -23.87%
Gross Margin: 0.00%
Operating Margin: -704.23%
Profit Margin: 0.00%
Current Ratio: 10.37
Debt/Equity: 0.02
Total Debt: $770.00K
Free Cash Flow: $-2.12M
Revenue Growth: -96.60%
Earnings Growth: —
Enterprise Value: $188.57M

SLGL Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$3.88M	$1.55M	$11.54M	$19.39M
Research & Development	$12.68M	$23.54M	$17.80M	$22.80M
Selling, General & Admin	$7.45M	$7.37M	$5.75M	$4.18M
Operating Expenses	$20.13M	$30.86M	$23.55M	$26.93M
Operating Income	-$16.24M	-$29.30M	-$12.01M	-$7.54M
EBITDA	-$15.68M	-$28.96M	-$11.78M	-$7.43M
Pretax Income	-$14.92M	-$27.24M	-$10.58M	-$6.13M
Net Income	-$14.92M	-$27.24M	-$10.58M	-$6.13M
Diluted EPS	-6.50	-10.01	-3.79	-2.19
Diluted Shares	2.31M	2.71M	2.79M	2.79M

SLGL Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$12.45M	$7.51M	$19.49M	$11.03M
Receivables	$7.92M	$377.00K	$3.60M	$1.97M
Current Assets	$43.05M	$41.17M	$31.30M	$26.97M
Total Assets	$46.63M	$45.29M	$35.85M	$29.92M
Current Liabilities	$3.33M	$4.52M	$5.29M	$6.17M
Total Debt	$772.00K	$1.65M	$1.31M	$991.00K
Total Liabilities	$4.42M	$6.64M	$7.00M	$7.11M
Retained Earnings	-$193.06M	-$220.30M	-$230.88M	-$237.01M
Shareholders' Equity	$42.21M	$38.64M	$28.85M	$22.81M
Working Capital	$39.73M	$36.65M	$26.01M	$20.80M

SLGL Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$9.48M	-$17.73M	-$13.89M	$322.00K
Capital Expenditure	-$171.00K	-$134.00K	-$2.00K	-$47.00K
Free Cash Flow	-$9.65M	-$17.86M	-$13.89M	$275.00K
Depreciation & Amortisation	$562.00K	$342.00K	$233.00K	$109.00K
Stock-Based Compensation	$1.53M	$1.86M	$786.00K	$82.00K
Investing Cash Flow	$1.70M	-$9.74M	$26.69M	-$8.58M
Financing Cash Flow	$15.00K	$21.81M	$0.00	$6.00K
Net Change in Cash	-$7.77M	-$5.66M	$12.80M	-$8.25M

SLGL Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$1.03M	$17.26M	$400.00K	$696.00K	$108.00K	$591.00K
Research & Development	$8.84M	$4.65M	$5.73M	$3.58M	$2.79M	$3.72M
Selling, General & Admin	$1.26M	$1.39M	$957.00K	$577.00K	$1.18M	$1.03M
Operating Expenses	$10.10M	$6.03M	$6.69M	$4.11M	$3.96M	$4.75M
Operating Income	-$9.07M	$11.23M	-$6.29M	-$3.41M	-$3.85M	-$4.16M
EBITDA	-$9.07M	$11.23M	-$6.29M	-$3.41M	-$3.85M	-$4.16M
Pretax Income	-$8.81M	$11.61M	-$5.94M	-$2.99M	-$3.73M	-$3.68M
Net Income	-$8.81M	$11.61M	-$5.94M	-$2.99M	-$3.73M	-$3.68M
Diluted EPS	-3.20	4.17	-2.13	—	-1.31	-1.13
Diluted Shares	2.79M	2.79M	2.79M	—	2.84M	3.27M

SLGL Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$16.89M	$10.22M	$6.71M	$11.03M	$10.14M	$16.66M
Receivables	$3.88M	$10.04M	$9.85M	$1.97M	$1.07M	$713.00K
Current Assets	$23.43M	$36.26M	$31.65M	$26.97M	$55.79M	$51.08M
Total Assets	$27.06M	$39.31M	$34.59M	$29.92M	$58.55M	$53.76M
Current Liabilities	$4.57M	$4.96M	$6.15M	$6.17M	$6.31M	$4.93M
Total Debt	$1.18M	$1.18M	$1.08M	$991.00K	$862.00K	$770.00K
Total Liabilities	$6.89M	$7.42M	$8.56M	$7.11M	$7.14M	$5.66M
Retained Earnings	-$239.69M	-$228.08M	-$234.02M	-$237.01M	-$240.74M	-$244.42M
Shareholders' Equity	$20.17M	$31.88M	$26.03M	$22.81M	$51.41M	$48.10M
Working Capital	$18.86M	$31.31M	$25.50M	$20.80M	$49.48M	$46.15M

Market Snapshot

About

Sol-Gel Technologies Ltd. is a dermatology company developing and commercializing topical therapies for skin diseases. The company utilizes its proprietary microencapsulation technology platform to create improved formulations of existing drugs and novel treatments. Sol-Gel markets products for acne, rosacea, and other dermatological conditions in the United States and internationally.